Michael Martens

24PUBLICATIONS
123CO-AUTHORS
Predictive and prognostic markersTransplantation immunologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jul 24, 2026
Group sequential clinical trial designs for composite endpoints incorporating recurrent and terminal events.

|May 27, 2026
TITE-safety: a robust time-to-event safety monitoring approach for clinical trials.

|Apr 06, 2026
Antigen-specific T-cell responses to SARS-CoV-2 vaccination after hematopoietic cell transplant or CAR T-cell therapy.

Sigrun Einarsdottir, Teng Fei, Katina H Singh

|Feb 27, 2026
Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 study.

Jakob Wirbel, Wael Saber, Michael J Martens

|Jul 30, 2025
Real-world outcomes of infections following tisagenlecleucel in patients with B-cell ALL: a CIBMTR analysis.

Hemalatha G Rangarajan, Prakash Satwani, Megan M Herr

|May 28, 2025
Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR.

Kitsada Wudhikarn, Megan M Herr, Min Chen

Pageof 4

Frequent Collaborators

7 joint publications

Miguel-Angel Perales

6 joint publications

Brent R Logan

6 joint publications

Mehdi Hamadani

5 joint publications

Wael Saber